Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
Jalloh I, Carpenter KLH, Grice P, Howe DJ, Mason A, Gallagher CN, et al
The cognitive benefit data is preliminary but compelling, and the longevity medicine community is watching that research space closely
From that point, the question of duration becomes one of goal achievement and maintenance strategy
Some newer medications (like tirzepatide, often grouped with GLP-1s) have shown higher weight loss up to ~20% in clinical studies
Your provider determines if it fits your goals